Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
100.00    -3.20 (-3.10%)
Bid:
100.20
Ask:
102.00
Spread: 1.80 (1.796%)
Market Cap: £163.94m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

10 Nov 2011 07:00

RNS Number : 8260R
Yule Catto & Co PLC
10 November 2011
 



10 November 2011

 

Yule Catto & Co plc (the "Group") 

 

Interim Management Statement

 

Yule Catto & Co plc (the "Group"), the international producer of speciality chemicals, today issues its interim management statement for the period 1 July to 9 November 2011.

 

The Group has performed well, in what has been a period of considerable economic uncertainty, and earnings for the third quarter were slightly ahead of the Board's expectations as at the date of the interim results.

 

The Polymers business saw generally softer demand across all regions compared to the first half of the year, as the customer destocking which started in July and August at the time of the Group's interim statement continued through the period resulting in a modest reduction in volumes. Monomer prices fell back through the period following the steep increases experienced through 2010 and the first half of 2011, with substantial falls in September and October. The benefit of weakening input prices and product price management ensured that third quarter pro-forma profitability continued to be comfortably ahead of prior year.

 

The delivery of synergies from the PolymerLatex acquisition continues to progress well and to plan. After six months of ownership, synergies had reached an annualised run rate of £8M at the end of the third quarter. The Board remains highly confident of achieving the planned annual synergies from the acquisition of at least £20M in the second 12 months post acquisition.

 

Pharma division profits year to date were similar to prior year.

 

Net debt reduced to £226M at the end of September from £240M at the end of June.

 

On 17 October, the Group announced the acquisition of Quality Polymer, a Malaysian aqueous polymer producer, expanding the Group's South East Asian production and sales of acrylic and vinylic polymer dispersions and adding a facility located close to Yule Catto's existing plant in Pasir Gudang.

 

The Board believes the current softer demand is attributable to destocking, along with some end market weakness. Based on current performance, the Board expects the Group will deliver full year earnings at least in line with current market expectations.

 

- Ends -

 

ENQUIRIES:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive

David Blackwood, Group Finance Director

MHP Communications

Tel: 020 3128 8100

Andrew Jaques

John Olsen

Ian Payne

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFLTLALAIIL
Date   Source Headline
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue
7th Sep 20237:00 amRNSHalf-year results
18th Jul 20237:00 amRNSPost-close trading update
12th Jul 20233:17 pmRNSAppointment of Non-Executive Director
28th Jun 202312:37 pmRNSDirector/PDMR Shareholding
28th Jun 202312:36 pmRNSDirector/PDMR Shareholding
22nd Jun 202310:20 amRNSDirector/PDMR Shareholding
16th May 20234:00 pmRNSResult of AGM
16th May 20237:00 amRNSAGM trading update
12th May 20231:08 pmRNSDirector/PDMR Shareholding
12th May 20231:06 pmRNSDirector/PDMR Shareholding
13th Apr 202310:02 amRNSHolding(s) in Company
12th Apr 20235:52 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSRefinancing
28th Feb 20233:33 pmRNSDisposal
31st Jan 20237:00 amRNSPost-close update for the year ended 31 Dec 2022
11th Jan 202311:30 amRNSResult of General Meeting
16th Dec 202212:12 pmRNSPublication of Circular &Notice of General Meeting
13th Dec 20227:00 amRNSProposed Sale of Laminates, Films & Coated Fabrics
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSBoard changes
29th Nov 202211:16 amRNSOutcome of European Commission investigation
1st Nov 20222:53 pmRNSHolding(s) in Company
27th Oct 202210:27 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSCovenant relaxation to the end of 2023 agreed
13th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSInvestor Seminar
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 202210:40 amRNSDirector/PDMR Shareholding
4th Oct 202210:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.